Litcius/Paper detail

HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells

Haiquan Lu, Yajing Lyu, Thi My Linh Tran, Jie Lan, Yangyiran Xie, Yongkang Yang, Naveena L. Murugan, Yueyang J. Wang, Gregg L. Semenza

2021Cell Reports49 citationsDOIOpen Access PDF

Abstract

Breast cancer stem cells (BCSCs) play essential roles in tumor formation, drug resistance, relapse, and metastasis. NANOG is a protein required for stem cell self-renewal, but the mechanisms by which it performs this function are poorly understood. Here, we show that hypoxia-inducible factor 1α (HIF-1α) is required for NANOG-mediated BCSC enrichment. Mechanistically, NANOG is recruited by HIF-1 to cooperatively activate transcription of the TERT gene encoding the telomerase reverse transcriptase that maintains telomere length, which is required for stem cell self-renewal. NANOG stimulates HIF-1 transcriptional activity by recruitment of the deubiquitinase USP9X, which inhibits HIF-1α protein degradation, and by stabilizing HIF-1α interaction with the coactivator p300, which mediates histone acetylation. Our results delineate a cooperative transcriptional mechanism by which HIF-1 and NANOG mediate BCSC self-renewal.

Topics & Concepts

Homeobox protein NANOGCoactivatorStem cellBiologyRex1Transcription factorCancer researchCell biologyCancer stem cellP300-CBP Transcription FactorsInduced pluripotent stem cellMolecular biologyEmbryonic stem cellGeneGeneticsHistone AcetyltransferasesCancer, Hypoxia, and MetabolismCancer Research and TreatmentsTelomeres, Telomerase, and Senescence